Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

GHRS stock hub

GH Research PLC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

GHRSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.3B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
GHRS
In the news

Latest news · GHRS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-21
P25 -105.6P50 -46.5P75 -3.1
ROIC-16.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All GHRS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001855129
Company name
GH Research PLC
Country
Ireland
Country code
US
Cusip
G3855L106
Employees
73
Employees Change
23%
Employees Change Percent
46
Enterprise value
$1B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2021-06-25
Isin
IE000GID8VI0
Last refreshed
2026-05-10
Market cap
$1.3B
Market cap category
Small-Cap
Price
$21.42
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
GHRS
Website
https://www.ghres.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-3.63%
FCF yield
-3.29%
P/B ratio
4.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-48.3M
Net Income Growth Years
0%
Profit Per Employee
$-661,068
ROA
-15.92
Roa5y
-11.11
ROCE
-21.68
ROE
-21.04
Roe5y
-14.17
ROIC
-16.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

4
MetricValue
Cagr1y
108.67%
Cagr3y
33.26%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
$288.2M
Cash
$280.7M
Current Assets
$286M
Current Liabilities
$8.4M
Debt
$512,000
Debt Equity
$0
Equity
$279.7M
Interest Coverage
-131
Liabilities
$8.5M
Long Term Assets
$2.3M
Long Term Liabilities
$147,000
Net Cash
$280.2M
Net Cash By Market Cap
$21.09
Net Cash Growth
53.95%
Net Debt Equity
$-1
Tangible Book Value
$279.7M
Tangible Book Value Per Share
$4.51
WACC
11.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
34.13
Net Working Capital
$-2.7M
Quick ratio
33.65
Working Capital
$277.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-17.33%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
1Y total return
108.57%
200-day SMA
14.74
3Y total return
136.69%
50-day SMA
16.77
50-day SMA vs 200-day SMA
50over200
All Time High
30.43
All Time High Change
-29.61%
All Time High Date
2021-11-19
All Time Low
5.05
All Time Low Change
324.16%
All Time Low Date
2023-12-18
ATR
1.38
Beta
1.28
Beta1y
1.58
Beta2y
1.16
Ch YTD
68.66
High
21.77
High52
24.66
High52 Date
2026-04-20
High52ch
-13.14%
Low
20.75
Low52
9.46
Low52 Date
2025-05-13
Low52ch
126.52%
Ma50ch
27.72%
Premarket Change Percent
2
Premarket Price
$21.43
Price vs 200-day SMA
45.32%
RSI
61.98
RSI Monthly
66.89
RSI Weekly
69.46
Sharpe ratio
1.26x
Sortino ratio
2.16
Total Return
-17.33%
Tr YTD
68.66
Tr1m
45.91%
Tr1w
3.43%
Tr3m
41.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
8
Analyst Count Top
5
Analyst Price Target Top
$42
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.26
Operating Income
$-60.7M
Price target
$41.38
Price Target Change
$93.18
Price Target Change Top
$96.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
22,801,591%
Float Percent
36.76%
Net Borrowing
-197,000
Shares Insiders
27.07%
Shares Institutions
39.43%
Shares Out
62,029,395
Shares Qo Q
0.02%
Shares Yo Y
17.33%
Short Float
9.43%
Short Ratio
14.82
Short Shares
3.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-52.2M
Average Volume
285,848.05x
Bv Per Share
4.51
CAPEX
$-121,000
Ch1m
45.91
Ch1w
3.43
Ch1y
108.6
Ch3m
41.25
Ch3y
136.7
Ch6m
58.67
Change
1.95%
Change From Open
2.15
Close
21.01
Days Gap
-0.19
Depreciation Amortization
77,000
Dollar Volume
3,437,995.7
Earnings Date
2026-05-22
Earnings Time
bmo
EBIT
$-60.7M
EBITDA
$-60.6M
EPS
$-0.79
F Score
2
FCF
$-43.7M
FCF EV Yield
-4.17x
FCF Per Share
$-0.7
Financing CF
139,651,000
Fiscal Year End
December
Founded
2,018
Investing CF
46,172,000
Ipr
33.88
Iprfo
-2.64
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-05
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-05
Ma150
15.2
Ma150ch
40.9%
Ma20
19.7
Ma20ch
8.72%
Net CF
145,460,000
Next Earnings Date
2026-05-22
Open
20.97
Optionable
Yes
Position In Range
65.69
Post Close
21.42
Postmarket Change Percent
-1.96
Postmarket Price
$21
Ppne
620,000
Pre Close
21.01
Price Date
2026-05-08
Ptbv Ratio
4.75
Relative Volume
0.56x
Share Based Comp
8,504,000
Tr6m
58.67%
Volume
160,504
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does GHRS pay a dividend?

Capital-return profile for this ticker.

Performance

GHRS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+108.6%
S&P 500 1Y: n/a
3Y total return
+136.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns GHRS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+39.4%
Float: +36.8% of shares outstanding
Insider ownership
+27.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+9.4%
14.8 days to cover
Y/Y dilution
+17.3%
Negative means the company is buying back shares.
Technical

GHRS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
62.0
Neutral momentum band
Price vs 200-day MA
+45.3%
50/200-day relationship not available
Beta (5Y)
1.28
More volatile than the market
Sharpe ratio
1.26
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About GHRS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GHRS stock rating?

GH Research PLC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GHRS analysis?

The full report lives at /stocks/GHRS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GHRS?

The latest report frames GHRS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GHRS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.